Search clinical trials for: TAK-536CCB Hydrochlorothiazide
Total 4878 results
-
TakedaCompletedEssential HypertensionJapan
-
TakedaCompletedGrade I or II Essential HypertensionJapan
-
Henan Cancer HospitalNot yet recruitingApplication of Douyin in Patients With Bone and Soft Tissue Malignant Tumors During PerichemotherapyChemotherapy | Malignant Tumor
-
Henan Cancer HospitalNot yet recruitingPerioperative Period | Malignant Tumor of Bone
-
Kaohsiung Medical University Chung-Ho Memorial...Completed
-
University of TasmaniaEnrolling by invitationDementia | Alzheimer Disease | Speech Disorders | Movement AbnormalitiesAustralia
-
TakedaCompleted
-
TakedaCompletedEssential HypertensionUnited States, Russian Federation
-
Oregon Research InstituteRecruitingAging | Mild Cognitive Impairment | Accidental FallsUnited States
-
US Department of Veterans AffairsCompleted
-
Afyonkarahisar Health Sciences UniversityRecruiting
-
ShireTakeda Development Center Americas, Inc.No longer availableAngioedema | Hereditary Angioedema (HAE)United States, Canada, Germany, Hungary, Spain
-
St. Luke's-Roosevelt Hospital CenterCompletedSubstance-Related Disorders | End Stage Liver Disease | End Stage Renal DiseaseUnited States
-
University of IcelandUppsala UniversityRecruitingIntrusive Memories of Traumatic Event(s)Iceland
-
TakedaWithdrawn
-
Kaohsiung Medical University Chung-Ho Memorial...UnknownMetastatic Colorectal CancerTaiwan
-
Neurocrine BiosciencesTakedaTerminatedSchizophrenia, Cerebellar AtaxiaUnited Kingdom
-
TakedaCompletedEssential HypertensionUnited States, Chile, Mexico
-
TakedaTerminatedAttention-Deficit/Hyperactivity DisorderUnited States
-
TakedaTerminatedCardiovascular Disease | Type 2 DiabetesUnited States, France, Poland, Ukraine, Germany, Hong Kong, Taiwan, Argentina, Israel, Mexico, Bulgaria, Malaysia, Romania, Canada, Korea, Republic of, New Zealand, Peru, Estonia, Philippines, Russian Federation, Czech Republic, H... and more
-
Millennium Pharmaceuticals, Inc.CompletedSystemic Lupus Erythematosus | Lupus Erythematosus, SystemicUnited States
-
TakedaTakeda Development Center Americas, Inc.CompletedPostoperative Gastrointestinal DysfunctionUnited States, Germany
-
Neurocrine BiosciencesTakedaCompletedSchizophrenia | Healthy VolunteersUnited States
-
Neurocrine BiosciencesTakedaCompletedDepressive DisorderUnited Kingdom
-
Millennium Pharmaceuticals, Inc.Completed
-
TakedaCompleted
-
TakedaTerminatedType 2 Diabetes MellitusTaiwan, China, Korea, Republic of, New Zealand, Australia
-
TakedaCompletedGastroesophageal Reflux Disease (GERD) | Erosive Esophagitis(EE)United Kingdom
-
TakedaWithdrawn
-
Millennium Pharmaceuticals, Inc.CompletedA Study of a Single Intravenous Infusion Dose of TAK-925 in Participants With Idiopathic HypersomniaIdiopathic HypersomniaUnited States, Japan
-
TakedaWithdrawnHealthy VolunteersUnited States
-
Neurocrine BiosciencesTakedaCompletedFriedreich AtaxiaUnited States
-
TakedaCompletedJapanese Healthy Adult Male ParticipantsJapan
-
TakedaCompletedHealthy ParticipantsUnited States
-
TakedaCompletedJapanese Healthy Adult MaleJapan
-
TakedaCompletedHealthy ParticipantsUnited States
-
TakedaCompleted
-
TakedaCompletedSafetyUkraine, Germany, Poland, Bulgaria, Netherlands, Lithuania, Slovakia, Latvia
-
TakedaCompletedHealthyUnited Kingdom
-
TakedaTakeda Development Center Americas, Inc.TerminatedCrohn DiseaseUnited States, Germany, Austria, France, United Kingdom
-
Neurocrine BiosciencesTakedaCompletedHealthy VolunteersUnited States
-
Millennium Pharmaceuticals, Inc.Terminated
-
TakedaCompletedMyasthenia GravisUnited States, Spain, Canada, Serbia, Italy, Poland
-
TakedaCompletedHealthy VolunteersUnited States
-
Neurocrine BiosciencesTakedaCompleted
-
National Cancer Institute (NCI)Not yet recruitingMyelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory High Risk Myelodysplastic Syndrome